NDC properties for "Gilenya 0.5 MG (as fingolimod HCl 0.56 MG) Oral Capsule" (RxCUI 1012899)
About this data
The tables show NDC propoerties for Gilenya 0.5 MG (as fingolimod HCl 0.56 MG) Oral Capsule with the RxCUI 1012899
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Gilenya 0.5 MG (as fingolimod HCl 0.56 MG) Oral Capsule (RxCUI 1012899)
| MMSL_CODE | BD26541 |
|---|---|
| NDA | NDA022527 |
| RxCUI | 1012899 |
| SPL_SET_ID | cc9e1c8c-0e2b-44e2-878b-27057f786be9 |
| Prescribable Synonym | Gilenya 0.5 MG Oral Capsule |
| RXNAV_STR | Gilenya 0.5 MG Oral Capsule |
| RxNorm Name | fingolimod 0.5 MG Oral Capsule [Gilenya] |
| RxNorm Synonym | Gilenya 0.5 MG (as fingolimod HCl 0.56 MG) Oral Capsule |
| RxNorm Synonym | Gilenya 0.5 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 1012899) |
NDC Properties
NDC Item 00078060715
| NDC 9 | 0078-0607 |
|---|---|
| NDC 10 | 0078-0607-15 |
| NDC Item | 00078060715 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0078-0607-15) |
| COLORTEXT | WHITE(white opaque body),YELLOW(bright yellow cap) |
| Color | C48325;C48330 __ |
| FDA SPL set id | 799165 |
| Imprint code | FTY;0;5;mg |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-09-21 |
| Marketing status | ACTIVE |
| NDA | NDA022527 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0078-0607 |
NDC Item 00078060789
| NDC 9 | 0078-0607 |
|---|---|
| NDC 10 | 0078-0607-89 |
| NDC Item | 00078060789 |
| Packaging | 7 CAPSULE in 1 CARTON (0078-0607-89) |
| COLORTEXT | WHITE(white opaque body),YELLOW(bright yellow cap) |
| Color | C48325;C48330 __ |
| FDA SPL set id | 799165 |
| Imprint code | FTY;0;5;mg |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-09-21 |
| Marketing status | ACTIVE |
| NDA | NDA022527 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0078-0607 |
NDC Item 00078060715
| NDC 9 | 0078-0607 |
|---|---|
| NDC 10 | 0078-0607-15 |
| NDC Item | 00078060715 |
| Packaging | 30 CAPSULE in 1 BOTTLE (0078-0607-15) |
| COLORTEXT | WHITE(white opaque body),YELLOW(bright yellow cap) |
| Color | C48325;C48330 __ |
| FDA SPL set id | 799165 |
| Imprint code | FTY;0;5;mg |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-09-21 |
| Marketing status | ACTIVE |
| NDA | NDA022527 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0078-0607 |
NDC Item 00078060789
| NDC 9 | 0078-0607 |
|---|---|
| NDC 10 | 0078-0607-89 |
| NDC Item | 00078060789 |
| Packaging | 7 CAPSULE in 1 CARTON (0078-0607-89) |
| COLORTEXT | WHITE(white opaque body),YELLOW(bright yellow cap) |
| Color | C48325;C48330 __ |
| FDA SPL set id | 799165 |
| Imprint code | FTY;0;5;mg |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-09-21 |
| Marketing status | ACTIVE |
| NDA | NDA022527 |
| Score | 1 |
| Shape | C48336 |
| Size | 16 mm |
| Related queries | Properties for NDC 9 0078-0607 |